Lipella Pharmaceuticals Inc.

Pittsburgh, PA

UEI
JBVNWFNEEV59
CAGE
480R9
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
7800 Susquehanna St Suite 505, Pittsburgh, PA 15208, USA
Website
lipella.com
Founded
2005
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Rapid point-of-care diagnostic kit for mosquito borne diseases in urine R43AI134529 National Institute of Allergy and Infectious Diseases (NIH) $210,554
Phenotyping interstitial cystitis/bladder pain syndrome by ICE-MRI based bladder permeability assay - interstitial… R44DK108397 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $2,699,196
Measuring bladder permeability with MRI using a novel contrast agent formulation R42DK108397 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $1,241,418
Measuring bladder permeability with MRI using a novel contrast agent formulation R41DK108397 National Institutes of Health $224,999
Preclinical development of tacrolimus for radiation cystitis R44DK102247 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $1,499,494

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Lipella Pharmaceuticals Inc. registered in SAM.gov?

Yes. Lipella Pharmaceuticals Inc.'s SAM.gov registration is active through December 18, 2026.

What is Lipella Pharmaceuticals Inc.'s most recent federal award?

Lipella Pharmaceuticals Inc.'s most recent federal grant award is Rapid point-of-care diagnostic kit for mosquito borne diseases in urine (R43AI134529), from National Institute of Allergy and Infectious Diseases (NIH), on August 1, 2017.

On GovTribe

See Lipella Pharmaceuticals Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login